SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SABRATEK CORP (SBTK)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ricardo Bekin who wrote (10)10/21/1997 5:16:00 PM
From: DD™  Read Replies (1) of 487
 
Bought some SBTK today following recent corrective price action and the following:

Tuesday October 21 2:04 PM EDT

RESEARCH ALERT - Sabratek raised

NEW YORK, Oct 21 (Reuters) - Jefferies & Co Inc said on Tuesday it had raised its rating on shares of Sabratek Corp to buy from accumulate.

said the recent share price pullback offered an excellent buying opportunity.

said accelerating recurring infusion set sales, combined with strong sales of Sabratek's infusion pumps, gives confidence the company will grow sales at a 68 percent compound annual rate from 1996 to 1999.

Analyst Carol Winslow said she was comfortable company would meet or exceed her third quarter earnings estimates.

DD
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext